A Randomized, Double Blind, Phase 3 Study of Chemotherapy with or without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic
Pancreatic
Pancreatic
III
Cardin, Dana
VICCGI26024
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Multiple Cancer Types
A first in human study to evaluate the safety and preliminary antitumor activity of BBO-11818, a pan-KRAS inhibitor, in subjects with locally advanced unresectable or metastatic KRAS mutant solid tumors.
Colon,
Lung,
Miscellaneous,
Pancreatic
I
Eng, Cathy
NCT06917079
VICCPHI25051
